Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 10, 2014 - Issue
Submit an article Journal homepage
70
Views
6
CrossRef citations to date
0
Altmetric
Review

Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer – role of radium-223

Deborah Mukherji1 Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, LebanonCorrespondence[email protected]
,
Imane El Dika1 Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon
,
Sally Temraz1 Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon
,
Mohammed Haidar2 Department of Nuclear Medicine, American University of Beirut Medical Center, Beirut, Lebanon
&
Ali Shamseddine1 Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon
Pages 373-380 | Published online: 23 May 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Angela Gernone, Sebastiano Bordonaro & Paolo Tralongo. (2015) Optimal sequence of bone target drugs in metastatic prostatic cancer. Expert Review of Anticancer Therapy 15:8, pages 923-929.
Read now

Articles from other publishers (5)

Asta Juzeniene, Vilde Yuli Stenberg, Øyvind Sverre Bruland & Roy Hartvig Larsen. (2021) Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer. Cancers 13:4, pages 779.
Crossref
Luigia Florimonte, Luca Dellavedova & Lorenzo Stefano Maffioli. (2016) Radium-223 dichloride in clinical practice: a review. European Journal of Nuclear Medicine and Molecular Imaging 43:10, pages 1896-1909.
Crossref
Xiaodong WangLauren C. HarshmanWanling XieMari NakabayashiFangfang QuMark M. PomerantzGwo-Shu Mary LeePhilip W. Kantoff. (2016) Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer . Journal of Clinical Oncology 34:4, pages 352-359.
Crossref
S. Boughdad, S. Le Moulec, C. Massard, F. Farace, P. Vielh, O. Aupée, D. Métivier, L. Védrine & E. Gontier. (2015) Évaluation de la réponse métabolique en TEP/TDM à la F18-FCH après un mois de traitement par acétate d’abiratérone chez les patients présentant un cancer de la prostate métastatique résistant à la castration. Médecine Nucléaire 39:4, pages 386-395.
Crossref
M.A. Chang, V. Patel, M. Gwede, M. Morgado, K. Tomasevich, E.L. Fong, M.C. Farach-Carson & Nikki A. Delk. (2014) IL-1β Induces p62/SQSTM1 and Represses Androgen Receptor Expression in Prostate Cancer Cells . Journal of Cellular Biochemistry 115:12, pages 2188-2197.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.